VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
Public ClinicalTrials.gov record NCT03820947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Global, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal™ Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early & Advanced Stage Superficial Venous Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Global, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal™ Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early and Advanced Stage Superficial Venous Disease
Study identification
- NCT ID
- NCT03820947
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 506 participants
Conditions and interventions
Conditions
Interventions
- VenaSeal™ System Device
- Endothermal Ablation (ETA) Device
- Surgical Stripping Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2020 (Actual)
- Primary completion
- Jun 12, 2024 (Actual)
- Completion
- Nov 10, 2025 (Actual)
- Last update posted
- Aug 25, 2026
2020 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yavapai Regional Medical Center | Prescott Valley | Arizona | 86314-2255 | — |
| PIMA Heart and Vascular | Tucson | Arizona | 85718 | — |
| Valley Vascular Surgical Associates | Fresno | California | 93701 | — |
| Vascular Care Connecticut | Darien | Connecticut | 06820 | — |
| Yale School of Medicine | New Haven | Connecticut | 06510 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007-2113 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Vascular Care Group | Wellesley | Massachusetts | 02482 | — |
| New York-Presbyterian Hospital/Weill Cornell Medical Center | New York | New York | 10024 | — |
| OhioHealth Riverside Methodist Hospital | Columbus | Ohio | 43214 | — |
| Orion Medical | Houston | Texas | 77034 | — |
| Lake Washington Vascular | Bellevue | Washington | 98004-4623 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03820947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2026 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03820947 live on ClinicalTrials.gov.